Literature DB >> 8958895

Effects of upper respiratory tract infections in patients with cystic fibrosis.

J Collinson1, K G Nicholson, E Cancio, J Ashman, D C Ireland, V Hammersley, J Kent, C O'Callaghan.   

Abstract

BACKGROUND: The polymerase chain reaction has improved the detection of picornaviruses and rhinoviruses and our understanding of their role in reversible airways disease. The effects of colds on lower respiratory morbidity and bacterial colonisation in cystic fibrosis remain uncertain.
METHODS: Children with cystic fibrosis were evaluated regularly in the clinic and the parents notified the investigators when their child developed a cold. Nasopharyngeal specimens were collected at the start of the infection for polymerase chain reaction, bacteriology was also undertaken and again three weeks later, and pulmonary function was measured in children aged > or = 6 years at four day intervals for three weeks. The effects of colds on rate of progression of cystic fibrosis were assessed by pulmonary function, Shwachman scores, and radiology.
RESULTS: Thirty eight children suffered 147 colds over 17 months. Picornaviruses were detected in 51 (43%) of 119 nasopharyngeal specimens, and 21 of the 51 were further identified as rhinoviruses. Pulmonary dysfunction was similar following picornavirus and non-picornavirus infections; the mean change from baseline in forced expiratory volume in one second (FEV1) was -16.5% and -10.3% at 1-4 days and 21-24 days, respectively, after onset of a cold. Children who experienced more colds than average had evidence of disease progression with reduction in Shwachman score, increasing Chrispin-Norman score, and greater deterioration in FEV1 per annum. Ten of 12 new bacterial infections were associated with a cold.
CONCLUSIONS: Picornavirus and non-picornavirus colds are associated with pulmonary function abnormalities and disease progression in patients with cystic fibrosis, and predispose to secondary bacterial infection and colonisation.

Entities:  

Mesh:

Year:  1996        PMID: 8958895      PMCID: PMC1090523          DOI: 10.1136/thx.51.11.1115

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  26 in total

1.  Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period.

Authors:  H SHWACHMAN; L L KULCZYCKI
Journal:  AMA J Dis Child       Date:  1958-07

2.  Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark.

Authors:  H K Johansen; N Høiby
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

3.  Acute respiratory illness in the community. Frequency of illness and the agents involved.

Authors:  A S Monto; K M Sullivan
Journal:  Epidemiol Infect       Date:  1993-02       Impact factor: 2.451

4.  Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis.

Authors:  A R Smyth; R L Smyth; C Y Tong; C A Hart; D P Heaf
Journal:  Arch Dis Child       Date:  1995-08       Impact factor: 3.791

5.  Community study of role of viral infections in exacerbations of asthma in 9-11 year old children.

Authors:  S L Johnston; P K Pattemore; G Sanderson; S Smith; F Lampe; L Josephs; P Symington; S O'Toole; S H Myint; D A Tyrrell
Journal:  BMJ       Date:  1995-05-13

Review 6.  Epidemiology of acute respiratory infections in children of developing countries.

Authors:  S Berman
Journal:  Rev Infect Dis       Date:  1991 May-Jun

7.  Respiratory viruses and exacerbations of asthma in adults.

Authors:  K G Nicholson; J Kent; D C Ireland
Journal:  BMJ       Date:  1993-10-16

8.  Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections.

Authors:  C G Pribble; P G Black; J A Bosso; R B Turner
Journal:  J Pediatr       Date:  1990-08       Impact factor: 4.406

9.  Improved detection of rhinoviruses in nasal and throat swabs by seminested RT-PCR.

Authors:  D C Ireland; J Kent; K G Nicholson
Journal:  J Med Virol       Date:  1993-06       Impact factor: 2.327

10.  Aetiology of community-acquired pneumonia in children treated in hospital.

Authors:  M Korppi; T Heiskanen-Kosma; E Jalonen; P Saikku; M Leinonen; P Halonen; P H Mäkela
Journal:  Eur J Pediatr       Date:  1993-01       Impact factor: 3.183

View more
  59 in total

1.  Respiratory syncytial virus pathophysiology and affect of palivizumab in special populations: cystic fibrosis and immunosuppression.

Authors:  Michael E Speer
Journal:  J Pediatr Pharmacol Ther       Date:  2011-04

2.  Cystic fibrosis and the war for iron at the host-pathogen battlefront.

Authors:  Nicole M Bouvier
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-22       Impact factor: 11.205

Review 3.  Spectrum of viral infections in patients with cystic fibrosis.

Authors:  H Frickmann; S Jungblut; T O Hirche; U Groß; M Kuhns; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

4.  Volatile fingerprinting of Pseudomonas aeruginosa and respiratory syncytial virus infection in an in vitro cystic fibrosis co-infection model.

Authors:  Giorgia Purcaro; Christiaan A Rees; Jeffrey A Melvin; Jennifer M Bomberger; Jane E Hill
Journal:  J Breath Res       Date:  2018-07-03       Impact factor: 3.262

5.  High Pseudomonas aeruginosa acquisition rate in CF.

Authors:  B E van Ewijk; T F W Wolfs; A Fleer; J L L Kimpen; C K van der Ent
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

6.  Rhinovirus infection liberates planktonic bacteria from biofilm and increases chemokine responses in cystic fibrosis airway epithelial cells.

Authors:  Sangbrita S Chattoraj; Shyamala Ganesan; Andrew M Jones; Jennifer M Helm; Adam T Comstock; Rowland Bright-Thomas; John J LiPuma; Marc B Hershenson; Umadevi S Sajjan
Journal:  Thorax       Date:  2011-02-02       Impact factor: 9.139

7.  Palivizumab, pneumococcal and influenza vaccination in cystic fibrosis.

Authors:  Mukta Jain; Anne H Thomson
Journal:  J R Soc Med       Date:  2009-07       Impact factor: 5.344

Review 8.  The airway epithelium: soldier in the fight against respiratory viruses.

Authors:  Marjolaine Vareille; Elisabeth Kieninger; Michael R Edwards; Nicolas Regamey
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 9.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

10.  The month of July: an early experience with pandemic influenza A (H1N1) in adults with cystic fibrosis.

Authors:  Megan W France; Szeanna Tai; Phillip J Masel; Vanessa L Moore; Tracy L McMahon; Alexander J Ritchie; Scott C Bell
Journal:  BMC Pulm Med       Date:  2010-02-25       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.